Niko McCarty - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Niko McCarty's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayNiko McCarty
Verified
Founding Editor, Asimov Press
Cambridge
Beats
Science media. health mental health technology
Oncology
Content
By Niko McCarty| asimov.com@ One reason David Goodsell’s paintings attract biologists, I think, is because they are unapologetically realistic. His paintings depict seas of macromolecules splayed out in pastel shades. A Goodsell painting looks nothing like the spacious diagrams one finds in high school biology textbooks, and that’s exactly why they linger in the mind: they show, visually, how crowded cells really are. But crowded with what, exactly? Well, an E.
By Niko McCarty| asimov.com@ A cell is a vibrating ball of energy — a chaotic sack of molecules. These molecules float around and collide with one another constantly. Every protein in a cell, for instance, collides with about 10 billion water molecules each second. Cells “work” despite this chaos. Most events within a cell only happen if the right things collide at the right time, and at sufficient frequencies. A DNA polymerase enzyme, for example, can only copy a genome if it first collides with the right part of DNA.
By Niko McCarty| asimov.com@ One reason David Goodsell’s paintings attract biologists, I think, is because they are unapologetically realistic. His paintings depict seas of macromolecules splayed out in pastel shades. A Goodsell painting looks nothing like the spacious diagrams one finds in high school biology textbooks, and that’s exactly why they linger in the mind: they show, visually, how crowded cells really are. But crowded with what, exactly? Well, an E.
Company Info
Asimov Press
Asimov is a biotechnology company founded in 2017 that focuses on integrating mammalian synthetic biology with computer-aided design to enhance therapeutic applications. The co-founders, including Alec Nielsen, Chris Voigt, and Doug Densmore, developed genetic logic circuit design tools during their time at MIT and Boston University. The company offers a variety of services and products centered around genetic design and cell engineering. Key offerings include genetic design tools for programming living cells, lentivirus production services to support cell and gene therapy development, and solutions for engineering mammalian systems for therapeutics, such as chimeric antigen receptor (CAR) therapies. Asimov's technology combines biological expertise with computational tools to streamline the design and production processes in the biotechnology sector.
Cambridge, United Kingdom
+1 617-849-9299
Founded: 2017